Related references
Note: Only part of the references are listed.Siglec receptors as new immune checkpoints in cancer
Michal A. Stanczak et al.
MOLECULAR ASPECTS OF MEDICINE (2023)
Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation
Shoib Sarwar Siddiqui
MOLECULAR ASPECTS OF MEDICINE (2023)
Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER plus breast cancer
Yasmin M. Attia et al.
PHARMACOLOGICAL REPORTS (2022)
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells
Daniela Huhn et al.
MOLECULAR ONCOLOGY (2022)
Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer
Saba Shafi et al.
LABORATORY INVESTIGATION (2022)
Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway
Zhuo Chen et al.
MEDICAL ONCOLOGY (2022)
Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections
Chiara Sfogliarini et al.
FRONTIERS IN PHARMACOLOGY (2022)
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
Annelie Johansson et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness
Kristine Cate S. Pe et al.
PLOS ONE (2022)
ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen
Giovanna Pepe et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
First Evidence for a Role of Siglec-8 in Breast Cancer
Anna Trebo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model
Przemyslaw Wielgat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Siglec Signaling in the Tumor Microenvironment
Eline J. H. van Houtum et al.
FRONTIERS IN IMMUNOLOGY (2021)
Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape
Mostafa Jarahian et al.
CANCERS (2021)
Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
Huimei Yi et al.
FRONTIERS IN ONCOLOGY (2021)
Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity
Itziar Ibarlucea-Benitez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Tamoxifen and oxidative stress: an overlooked connection
Nermin S. Ahmed et al.
DISCOVER ONCOLOGY (2021)
Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
Karim Perez-Romero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity
Zoheir Dahmani et al.
PLOS ONE (2020)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Manuel A. Ferreira et al.
NATURE COMMUNICATIONS (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
Vanessa Barriga et al.
CANCERS (2019)
The sialoglycan-Siglec-E checkpoint axis in dexamethasone-induced immune subversion in glioma-microglia transwell co-culture system
Przemyslaw Wielgat et al.
IMMUNOLOGIC RESEARCH (2019)
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
Diana C. Marquez-Garban et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells
Liliana Torres-Lopez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti-Mays et al.
NPJ BREAST CANCER (2019)
Inflammation induced PD-L1-specific T cells
Shamaila Munir et al.
CELL STRESS (2019)
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Joyce Lubbers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
Nikolaos Svoronos et al.
CANCER DISCOVERY (2017)
Viewing Siglecs through the lens of tumor immunology
Isabella Fraschilla et al.
IMMUNOLOGICAL REVIEWS (2017)
Tamoxifen promotes apoptosis and inhibits invasion in estrogen-positive breast cancer MCF-7 cells
Wei Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Tamoxifen as an immunotherapy
Leslie K. Ferrarelli
Science Signaling (2017)
Tamoxifen as an immunotherapy
Leslie K. Ferrarelli
Science Signaling (2017)
PD-1/PD-L1 Pathway in Breast Cancer
Florian Schuetz et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Breast Cancer-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
Armando E. Giuliano et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Sialic acids in cancer biology and immunity
Oliver M. T. Pearce et al.
GLYCOBIOLOGY (2016)
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
Richard Beatson et al.
NATURE IMMUNOLOGY (2016)
Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4
Xiaolu Ma et al.
CELL DEATH & DISEASE (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Role of the Tumor Microenvironment in Breast Cancer
Savas D. Soysal et al.
PATHOBIOLOGY (2015)
Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus
Syed Raza Ali et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells
Chun-Yu Liu et al.
BREAST CANCER RESEARCH (2014)
Binding of the Sialic Acid-binding Lectin, Siglec-9, to the Membrane Mucin, MUC1, Induces Recruitment of β-Catenin and Subsequent Cell Growth
Shuhei Tanida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by tamoxifen through c-Jun transcription factors
Yan Xu et al.
MOLECULAR MEDICINE REPORTS (2013)
Siglecs and Immune Regulation
Shiv Pillai et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Sialidase significance for cancer progression
Taeko Miyagi et al.
GLYCOCONJUGATE JOURNAL (2012)
Arginase Activity in Patients with Breast Cancer: An Analysis of Plasma, Tumors, and Its Relationship with the Presence of the Estrogen Receptor
Gabriel Perez et al.
ONKOLOGIE (2012)
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug
Matteo Lazzeroni et al.
BREAST CANCER RESEARCH (2012)
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E. Place et al.
BREAST CANCER RESEARCH (2011)
Beyond glycosylation: sialic acid precursors act as signaling molecules and are involved in cellular control of differentiation of PC12 cells
Maria Kontou et al.
BIOLOGICAL CHEMISTRY (2009)
The Effects of Tamoxifen on Immunity
S. Behjati et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Deletion polymorphism of SIGLEC14 and its functional implications
Masahiro Yamanaka et al.
GLYCOBIOLOGY (2009)
Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates
Takashi Angata et al.
FASEB JOURNAL (2006)
Tamoxifen inhibition of estrogen receptor-α-negative mouse mammary tumorigenesis
D Medina et al.
CANCER RESEARCH (2005)
Share Paper
